Eczema by Age Group: How Symptoms Change from Birth to 65+

What Is Eczema and Why Does Age Matter?

Atopic dermatitis (the most common form of eczema) is a chronic inflammatory skin disease driven by immune dysregulation and skin barrier defects. It affects up to 20% of children and about 2–10% of adults globally.^[1] Those numbers alone hint at something important: eczema by age group is not a flat line. Prevalence peaks in early childhood, dips in adolescence, and then follows a more complex pattern in adulthood and old age.

Age shapes nearly every aspect of the disease. The body sites where rashes appear shift as you grow. Triggers evolve from food allergens in infancy to occupational irritants in adulthood. Even the texture of the rash changes, moving from oozing, crusted patches in babies to thick, leathery skin in adults who have scratched for years.^[2] For more foundational facts, see our key facts about eczema.

One framework ties these age-related changes together: the atopic march.

The Atopic March: Eczema's Role in a Larger Pattern

The atopic march describes a typical sequence in which eczema appears first, often in infancy, followed by food allergy, then asthma, and finally allergic rhinitis as the child grows. Children with a strong family history of these conditions may be at higher risk — see our guide on whether atopic dermatitis is hereditary for more on family risk patterns.^[3] Not every child follows this path. But studies estimate that about 30% of children with atopic dermatitis go on to develop asthma, and roughly 66% develop allergic rhinitis.^[4]

Understanding the atopic march matters because it reframes eczema as more than a skin problem. It is often the first visible sign of a broader allergic tendency. Early, effective management of eczema may influence whether later allergic conditions develop, though research on this "prevention window" is still evolving.^[5]

The practical takeaway: eczema is not just a rash to manage in the moment. It is a signal that the immune system may be on a trajectory worth monitoring at every age.

That trajectory starts remarkably early. Here is what eczema looks like in the first two years of life.

Eczema in Newborns and Infants (Birth to 2 Years)

Infant eczema is common. Prevalence in the first year of life ranges from 15% to 20% in many industrialized countries.^[6] Most cases appear between two and six months of age, though some babies show signs as early as the first few weeks.^[6]

The infant skin barrier is still maturing. Transepidermal water loss (TEWL) is higher in newborns, and the stratum corneum is thinner than in older children.^[7] This immaturity makes baby skin more vulnerable to irritants, allergens, and dryness. It also explains why early emollient use from birth has shown promise in reducing eczema risk in high-risk infants, though results across trials have been mixed.^[8]

Food allergens play a notable role at this stage. Up to 30% of infants with moderate-to-severe eczema also have a confirmed food allergy, most often to cow's milk, egg, or peanut.^[9] For a deeper look at what drives infant eczema, see our guide on what causes eczema in babies.

Common Body Locations in Infants

Baby eczema favors specific areas that differ from older children:

• Cheeks and forehead: The most recognizable pattern in infants, often appearing as red, scaly patches on both cheeks.^[2]
• Scalp: Eczema on the scalp can overlap with or follow cradle cap (seborrheic dermatitis).
• Extensor surfaces: The outer arms and fronts of the legs are common sites, the opposite of the flexural pattern seen in older children.^[2]
• Trunk: Widespread patches on the chest and back occur in more severe cases.

The diaper area is typically spared in atopic dermatitis because moisture retention in that zone actually protects the skin barrier. If you see a rash mainly in the diaper area, it is more likely irritant diaper dermatitis. Our article on diaper rash cream and eczema explains the difference. For Dr. Harlan's specific treatment protocol for infants with atopic dermatitis, see the Atopic Dermatitis / Eczema (Infants) help guide.

Distinguishing Infant Eczema from Other Rashes

Several common newborn rashes mimic eczema:

• Cradle cap (seborrheic dermatitis): Greasy, yellowish scales on the scalp, usually not itchy.^[10]
• Baby acne (neonatal cephalic pustulosis): Small red bumps on the face, typically resolving by 3–4 months.
• Contact dermatitis: Rash limited to areas touching an irritant (drool rash around the mouth, for example).

For a side-by-side comparison, see our guide on baby acne vs. eczema.

As toddlers grow into school-age children, the rash begins a notable migration. Here is where it goes next.

Eczema in Children (Ages 2 to 11)

Eczema prevalence peaks during childhood. Population-based studies confirm that children have the highest rates of atopic dermatitis of any age group, with prevalence in children estimated at up to 20% in many industrialized countries.^[1] This makes the elementary school years the period when eczema by age group reaches its highest point.

The Flexural Shift: How Body Locations Change

Between ages two and four, eczema migrates from the face and extensor surfaces to the flexural areas: the inner elbows (antecubital fossae), behind the knees (popliteal fossae), wrists, and ankles.^[2] This shift is so consistent that clinicians use it as a diagnostic marker.

Chronic scratching at these sites leads to lichenification, a thickening and darkening of the skin that develops over months of repeated rubbing.^[11] You may notice your child's skin in the elbow creases becoming leathery and deeply lined. This is not a new condition. It is the same eczema, reshaped by time and friction. Understanding how to manage nighttime itching is especially important during these years, when scratching during sleep drives much of the damage.

Environmental triggers become more prominent during these years. Dust mites, pet dander, and seasonal pollen can all provoke flares.^[12] School-related exposures matter too: chlorinated pool water, playground sand, and craft supplies with fragrances or dyes can irritate already-compromised skin. For a deeper look at triggers, see our article on seven eczema triggers backed by science.

Quality of Life and the School-Age Child

The burden of childhood eczema extends well beyond the skin. Studies using the Children's Dermatology Life Quality Index (CDLQI) show that moderate-to-severe eczema impacts quality of life as much as or more than asthma and diabetes in children.^[13] Sleep disruption is the most common complaint, with up to 60% of children with eczema experiencing disturbed sleep during flares.^[14]

Think about what that means in practice: a child who scratches through the night arrives at school exhausted, struggles to concentrate, and may avoid activities like swimming or sports that expose irritated skin. The ripple effects touch academic performance, friendships, and family stress.^[13]

But childhood is also when many families first notice improvement. As the immune system matures and the skin barrier strengthens, a significant number of children begin to see their eczema fade. Whether that improvement lasts through the teen years is another question entirely.

Eczema in Teenagers (Ages 12 to 17)

Eczema prevalence drops somewhat in adolescence compared to the peak childhood years. That dip is encouraging, but it masks a more complex reality. For the teens who still have eczema, the disease often intensifies in ways that go beyond the skin.

Puberty, Hormones, and Flare Patterns

Puberty introduces hormonal shifts that can reshape eczema patterns. Rising levels of androgens and estrogens influence sebum production, immune cell activity, and skin barrier function.^[15] Some teens notice flares tied to their menstrual cycle. Others find that increased sweating during sports triggers intense itching in flexural areas.

Body locations may shift again during adolescence, with some teens experiencing more involvement of the hands, face, and eyelids as hormonal and environmental exposures change. These visible areas carry an outsized emotional weight during a life stage defined by self-image and social comparison.

Treatment adherence also drops sharply in this age group. Teens may skip moisturizers, forget topical medications, or refuse treatments they find messy or time-consuming. Dr. Harlan's atopic dermatitis protocol for teenagers offers practical guidance on building a routine that teens are more likely to follow.^[16]

The Mental Health Connection in Adolescents

The psychosocial burden of eczema in teens deserves serious attention. Adolescents with atopic dermatitis have significantly higher rates of depression and anxiety compared to their peers without eczema. Learning to feel confident with eczema is a skill that can be developed with the right strategies.^[17] One large population-based study found that teens with eczema were about 1.5 to 2 times more likely to report depressive symptoms.^[18]

For many teens, the burning question is simple: will this ever go away? The answer depends on several factors we will explore shortly. But first, here is what happens when eczema follows you into adulthood, or shows up for the first time.

Eczema in Adults (Ages 18 to 64)

Adult eczema affects roughly 7–10% of the population in the United States and Europe.^[19] For years, clinicians viewed atopic dermatitis as primarily a childhood disease. That view has changed. Research now recognizes two distinct adult populations: those whose childhood eczema persisted, and those who develop eczema for the first time as adults.

Adult-Onset Eczema: A Growing Recognition

Studies suggest that a substantial proportion of adults with atopic dermatitis report onset after age 18, with no childhood history of the disease — with some cohort studies finding that 40–43% of those with atopic eczema at any point reported first onset in adulthood.^[20] Adult-onset eczema may present differently from childhood patterns, and clinicians should consider a broad differential diagnosis when evaluating new eczema in adults. For example, hand eczema is one of the most common presentations in adults with no prior childhood history.

This late onset can be confusing. Adults who never had eczema as children may not recognize what they are dealing with. Clinicians must also rule out other conditions that mimic eczema in adults, including allergic contact dermatitis, cutaneous T-cell lymphoma, and psoriasis.

Hormonal Life Stages and Eczema Flares

Hormonal transitions throughout adulthood can trigger or worsen eczema. Pregnancy is a notable example: atopic eruption of pregnancy is the most common pregnancy-related skin condition, and women with a history of eczema often experience flares during pregnancy, particularly in the second and third trimesters.^[21]

The postpartum period brings its own challenges, with sleep deprivation, stress, and hormonal shifts combining to provoke flares. For guidance on this specific stage, see our article on managing postpartum eczema.

Perimenopause and menopause also affect eczema. Declining estrogen levels reduce skin hydration and barrier function, which can trigger new-onset eczema or reactivate dormant disease. For a deeper look at how hormones drive these patterns throughout life, see our article on whether hormones cause eczema.^[22] Our guide on caring for your skin at menopause covers this transition in detail.

Occupational Eczema and Hand Involvement

Hand eczema is the most common occupational skin disease, and adults with a history of atopic dermatitis are at significantly higher risk.^[23] Healthcare workers, hairdressers, food handlers, cleaners, and construction workers face the highest rates due to frequent wet work, chemical exposure, and glove use.^[24]

The economic impact is substantial. Adults with moderate-to-severe atopic dermatitis report significantly more missed workdays and reduced productivity compared to those without the condition.^[25] One study estimated that the annual indirect costs of atopic dermatitis in adults, including lost work productivity, exceeded $2,000 per patient.^[26]

As adults age into their 60s and beyond, eczema takes on yet another character. The skin itself changes in ways that create entirely new patterns of disease.

Eczema in Older Adults (Ages 65 and Older)

Elderly eczema is often underdiagnosed and undertreated. Prevalence estimates vary widely, but studies suggest that eczematous conditions affect 20–40% of older adults when all subtypes are included.^[27] The challenge is that eczema in this age group often looks different from classic atopic dermatitis, and it frequently overlaps with other conditions.

Age-Related Skin Barrier Decline

Aging fundamentally changes the skin barrier. Ceramide levels, which are critical for moisture retention, decline with age.^[28] Sebaceous gland output drops, reducing the natural lipid film that protects the skin surface. The stratum corneum becomes less efficient at holding water, and the rate of epidermal turnover slows.^[29]

These changes create a skin environment that is drier, more fragile, and more susceptible to irritation. Even mild exposures, such as overwashing with soap, low humidity, or rough clothing, can trigger eczematous reactions in older skin that would have tolerated them decades earlier.^[29]

Types of Eczema More Common in Later Life

Three eczema subtypes become particularly common in older adults:

• Asteatotic eczema (eczema craquelé): Dry, cracked skin with a "crazy paving" pattern, most common on the shins. It results directly from age-related barrier decline and low humidity.^[28]
• Stasis dermatitis: Red, scaly, sometimes weeping skin on the lower legs, driven by chronic venous insufficiency. Studies report prevalence of approximately 6–7% in adults aged 65 and older, with rates rising further in those with established venous disease.^[30] For a complete overview, see our guide to stasis dermatitis.
• Nummular eczema: Coin-shaped, well-defined plaques that can appear anywhere on the body and are among the eczema subtypes seen in older adults, often in the context of dry skin conditions.

For a broader look at these and other subtypes, see our article on different types of eczema.

Treatment in older adults requires extra caution. Skin fragility increases the risk of steroid-induced atrophy. Drug interactions limit systemic options. And the risk of secondary skin infections rises with age and immune senescence. For adults managing eczema day to day, Dr. Harlan's Atopic Dermatitis / Eczema (Adults) protocol provides a structured starting point.^[27]

Now that you have seen how eczema presents at each life stage, the next question is: how does it actually move through a single person's life over time?

How Eczema Changes Over a Lifetime

Eczema is not a single episode. It is a chronic condition with a pattern of remission and relapse that can span decades. Understanding that pattern helps you plan for the long term rather than reacting to each flare as if it were a new crisis.

Will My Child Outgrow Eczema?

This is one of the most common questions parents ask. The answer is cautiously optimistic. Longitudinal studies suggest that roughly 60–70% of children with atopic dermatitis experience significant improvement or complete remission by adolescence.^[32]

However, "outgrowing" eczema does not always mean it is gone for good. A substantial proportion of those who improve in childhood experience relapse in adulthood. One cohort study found that about 50% of individuals who had childhood eczema reported recurrence of symptoms at some point during adult life.^[33]

What this means for your family: even if your child's eczema improves dramatically, maintaining good skin barrier habits (regular moisturizing, gentle cleansing, trigger avoidance) is worth continuing. The underlying tendency does not disappear. It may simply go quiet for a while.

Predictors of Lifelong Eczema

Research has identified several factors that predict whether eczema will persist rather than resolve:

• Early onset and severity: Children with severe eczema in the first two years of life are more likely to have persistent disease.^[32]
• Filaggrin gene mutations: Loss-of-function mutations in the filaggrin gene, which encodes a key skin barrier protein, are strongly associated with persistent and more severe atopic dermatitis.^[34] Learn more about the genetic basis in our article on eczema and genetics.
• Allergic comorbidities: Children who develop asthma or food allergies alongside eczema are less likely to see full remission.^[4]
• Family history: A strong family history of atopic disease increases the likelihood of lifelong eczema.

These predictors are not destiny. They are signals that help you and your doctor plan a more proactive management strategy. Families dealing with persistent eczema may also want to explore what causes atopic dermatitis reactions to better understand the underlying drivers. And that brings us to the question of treatment, which also changes significantly across the lifespan.

Age-Appropriate Treatment Principles

The core of eczema treatment stays the same at every age: restore the skin barrier, reduce inflammation, and control itch. But the specific tools you use, and the caution required, shift with each life stage.

Topical Treatments Across the Age Spectrum

Emollients are the foundation of eczema care from birth through old age. Regular moisturizer use reduces flare frequency and steroid need across all age groups.^[35] The key is consistency: applying a thick, fragrance-free emollient at least twice daily, and immediately after bathing.

Topical corticosteroids remain the first-line anti-inflammatory treatment. However, potency selection must match the patient's age and the body site being treated:

• Infants: Low-potency steroids (e.g., hydrocortisone 1%) for limited periods, avoiding the face and diaper area when possible.^[36]
• Children: Low-to-medium potency for flexural areas; medium potency for trunk and limbs.
• Teens and adults: Medium-to-high potency for body; low potency for face and intertriginous areas.
• Elderly: Extra caution due to skin fragility and increased risk of steroid-induced atrophy.^[27]

Topical calcineurin inhibitors (tacrolimus and pimecrolimus) offer a steroid-sparing option, particularly for sensitive areas like the face and eyelids. Tacrolimus 0.03% ointment is approved for children aged 2 and older, while the 0.1% formulation is approved for adults.^[37] Pimecrolimus cream is also approved for ages 2 and up.^[37]

Most over-the-counter options address only one piece of the puzzle. Plain moisturizers hydrate but do not calm inflammation. OTC anti-inflammatories like 1% hydrocortisone offer limited potency and carry side-effect risk with prolonged use. Prebiotic moisturizers support the microbiome but lack an anti-inflammatory component for active flares.

SmartLotion is a different kind of treatment. Developed by a board-certified dermatologist at HarlanMD, it combines all three pillars of eczema management in one formulation: a light anti-inflammatory (0.75% hydrocortisone) where the sulfur in the formula actively prevents steroid side effects, a prebiotic blend (glycerin, sulfur, grapefruit seed extract) that supports the skin's natural microbiome, and moisturizing action. That combination makes it safe for multiple daily applications on even sensitive skin, at any age. Dr. Harlan has used it successfully in patients under 2 for over 30 years.

When to Consider Systemic Therapy

When topical treatments are not enough, systemic options become relevant. The landscape has expanded dramatically in recent years:

• Dupilumab: A biologic targeting IL-4 and IL-13, approved for moderate-to-severe atopic dermatitis in patients aged 6 months and older.^[38]
• Tralokinumab: An IL-13 inhibitor approved for adults with moderate-to-severe atopic dermatitis.^[39]
• JAK inhibitors (abrocitinib, upadacitinib): Oral medications approved for adults and, in some cases, adolescents aged 12 and older with moderate-to-severe disease.^[40]

For older adults, systemic therapy requires careful consideration of kidney function, liver function, and drug interactions. Traditional immunosuppressants like cyclosporine and methotrexate carry higher risks in this population.^[27]

For a complete overview of treatment options, see our atopic dermatitis treatments guide. For severe flares, Dr. Harlan often pairs a prescription-strength steroid with SmartLotion for initial control, then tapers to SmartLotion alone for ongoing maintenance.

Frequently Asked Questions About Eczema by Age

At What Age Does Eczema Usually Start?

Most cases of atopic dermatitis begin in infancy or early childhood. About 60% of cases appear within the first year of life,^[6] and approximately 80% develop before age six. However, eczema can start at any age, including in older adults.

Can You Develop Eczema for the First Time as an Adult?

Yes. Research shows that a substantial proportion of adults with atopic dermatitis report their first symptoms after age 18 — cohort studies have found that 40–43% of those with atopic eczema reported adult onset, and among adults with active eczema at any given survey point, the majority had no childhood history of the disease.^[20] Adult-onset eczema may present differently from childhood eczema. If you develop a new, persistent, itchy rash as an adult, see a dermatologist for proper diagnosis.

What Age Group Is Most Affected by Eczema?

Children have the highest reported prevalence of eczema of any age group. Prevalence remains elevated in infants, toddlers, and school-age children, drops somewhat in adolescence, and is estimated at 7–10% in adults.^[19]

Does Eczema Get Better or Worse with Age?

For most children, eczema improves with age. About 60–70% of children see significant improvement by adolescence.^[32] However, some people experience persistent disease into adulthood, and others develop new eczema subtypes (like asteatotic eczema) in old age.^[28] The trajectory varies widely from person to person.

References

1. Brown SJ. "Atopic eczema." Clinical Medicine (London). 2016. View Study
2. Chatrath S, Silverberg JI. "Phenotypic differences of atopic dermatitis stratified by age." JAAD International. 2023. View Study
3. Kalb B, Khaleva E, Giovannini M, et al. "Trajectories of allergic diseases in children: Destination unknown?" Pediatric Allergy and Immunology. 2025. View Study
4. Leshem YA, Weil C, Busse WW, Beck LA, Chodick G, Cyr SL, Bosman K, Lubwama R. "Real-World Onset of Atopic Comorbidities Relative to Atopic Dermatitis in Pediatric Patients." Dermatology and Therapy. 2025. View Study
5. Tsuge M, Ikeda M, Matsumoto N, Yorifuji T, Tsukahara H. "Current Insights into Atopic March." Children (Basel, Switzerland). 2021. View Study
6. Ziyab AH, Mukherjee N, Zhang H, Arshad SH, Karmaus W. "Sex-specific developmental trajectories of eczema from infancy to age 26 years: A birth cohort study." Clinical and Experimental Allergy. 2022. View Study
7. Summers A, Visscher M, Khatry SK, Sherchand JB, LeClerq SC, Katz J, Tielsch JM, Mullany LC. "Indicators of skin barrier integrity among newborns massaged with mustard oil in rural Nepal." Journal of Perinatology. 2018. View Study
8. Kelleher MM, Cro S, Cornelius V, et al. "Skin care interventions in infants for preventing eczema and food allergy." Cochrane Database of Systematic Reviews. 2021. View Study
9. Kopp MV, Muche-Borowski C, Abou-Dakn M, et al. "S3 Guideline Allergy Prevention." Allergologie select. 2022. View Study
10. Victoire A, Magin P, Coughlan J, van Driel ML. "Interventions for infantile seborrhoeic dermatitis (including cradle cap)." Cochrane Database of Systematic Reviews. 2019. View Study
11. Young-Won Kim, Tong Zhou, Eun-A Ko, et al. "Prediction of itching diagnostic marker through RNA sequencing of contact hypersensitivity and skin scratching stimulation mice models." Korean Journal of Physiology & Pharmacology. 2019. View Study
12. Bumbacea RS, Corcea SL, Ali S, Dinica LC, Fanfaret IS, Boda D. "Mite allergy and atopic dermatitis: Is there a clear link? (Review)." Experimental and Therapeutic Medicine. 2020. View Study
13. Simpson EL, de Bruin-Weller M, Eckert L, et al. "Responder Threshold for Patient-Oriented Eczema Measure (POEM) and Children's Dermatology Life Quality Index (CDLQI) in Adolescents with Atopic Dermatitis." Dermatology and Therapy. 2019. View Study
14. Fishbein AB, Cheng BT, Tilley CC, Smith Begolka W, Carle AC, Forrest CB, Zee PC, Paller AS, Griffith JW. "Sleep Disturbance in School-Aged Children with Atopic Dermatitis: Prevalence and Severity in a Cross-Sectional Sample." The Journal of Allergy and Clinical Immunology: In Practice. 2021. View Study
15. Gratton R, Del Vecchio C, Zupin L, Crovella S. "Unraveling the Role of Sex Hormones on Keratinocyte Functions in Human Inflammatory Skin Diseases." International Journal of Molecular Sciences. 2022. View Study
16. Zvulunov A, Lenevich S, Migacheva N. "Mobile Health App as an Auxiliary Tool in Management of Atopic Dermatitis in Children: Randomized Controlled Trial." JMIR Dermatology. 2025. View Study
17. Lugović-Mihić L, Bukal D, Dolački L, Zanze L, Barac E, Tomašević R, Vilibić M. "Mental Health, Psychological Features and Psychiatric Comorbidity of Adolescents with Atopic Dermatitis: A Review." Pediatric Reports. 2025. View Study
18. Kern C, Wan J, LeWinn KZ, Ramirez FD, Lee Y, McCulloch CE, Langan SM, Abuabara K. "Association of Atopic Dermatitis and Mental Health Outcomes Across Childhood: A Longitudinal Cohort Study." JAMA Dermatology. 2021. View Study
19. Chan LN, Magyari A, Ye M, Al-Alusi NA, Langan SM, Margolis D, McCulloch CE, Abuabara K. "The epidemiology of atopic dermatitis in older adults: A population-based study in the United Kingdom." PLoS One. 2021. View Study
20. Abuabara K, Ye M, McCulloch CE, Sullivan A, Margolis DJ, Strachan DP, Paternoster L, Yew YW, Williams HC, Langan SM. "Clinical onset of atopic eczema: Results from 2 nationally representative British birth cohorts followed through midlife." Journal of Allergy and Clinical Immunology. 2020. View Study
21. Keeling E, Smith CH, Woolf RT. "The management of severe eczema in pregnancy." Clinical Medicine (London). 2025. View Study
22. Kendall AC, Pilkington SM, Wray JR, Newton VL, Griffiths CEM, Bell M, Watson REB, Nicolaou A. "Menopause induces changes to the stratum corneum ceramide profile, which are prevented by hormone replacement therapy." Scientific Reports. 2022. View Study
23. Visser MJ, Verberk MM, Campbell LE, McLean WHI, Calkoen F, Bakker JG, van Dijk FJH, Bos JD, Kezic S. "Filaggrin loss-of-function mutations and atopic dermatitis as risk factors for hand eczema in apprentice nurses: part II of a prospective cohort study." Contact Dermatitis. 2014. View Study
24. Srinivas CR, Sethy M. "Occupational Dermatoses." Indian Dermatology Online Journal. 2023. View Study
25. Silverberg JI, Anderson P, Cappelleri JC, Piercy J, Levenberg ME, Myers DE, Gerber RA. "Burden of mild and moderate atopic dermatitis in adults: results from a real-world study in the United States." Archives of Dermatological Research. 2025. View Study
26. Beretzky Z, Koszorú K, Rencz F, Hajdu K, Borza J, Bodai K, Xu F, Szegedi A, Sárdy M, Brodszky V. "Societal costs and health related quality of life in adult atopic dermatitis." BMC Health Services Research. 2023. View Study
27. Merola JF, Butler DC, Mark T, Schneider S, Kim Y, Abuabara K. "Safety and Efficacy of Tralokinumab in Older Adults With Moderate-to-Severe Atopic Dermatitis: A Secondary Analysis." JAMA Dermatology. 2023. View Study
28. Williams SF, Andrew P, Brown K, Chittock J, Pinnock A, Poyner A, Cork MJ, Danby SG. "The Impact of Age on the Lipidomic Profile of the Stratum Corneum and Associated Effects on Structure, Function and Overall Skin Health in Adults Predisposed to Atopic Dermatitis." Experimental Dermatology. 2025. View Study
29. Kim J, Nakasaki M, Todorova D, Lake B, Yuan C-Y, Jamora C, Xu Y. "p53 induces skin aging by depleting Blimp1+ sebaceous gland cells." Cell Death & Disease. 2014. View Study
30. Yosipovitch G, Nedorost ST, Silverberg JI, Friedman AJ, Canosa JM, Cha A. "Stasis Dermatitis: An Overview of Its Clinical Presentation, Pathogenesis, and Management." American Journal of Clinical Dermatology. 2023. View Study
31. Maher RL, Hanlon JT, Hajjar ER. "Clinical Consequences of Polypharmacy in Elderly." Expert Opinion on Drug Safety. 2014. View Study
32. Hung CW, Roll S, Icke K, et al. "Incidence and Remission of Atopic Dermatitis in a German Birth Cohort." JAMA Network Open. 2025. View Study
33. Kim JP, Chao LX, Simpson EL, Silverberg JI. "Persistence of atopic dermatitis (AD): A systematic review and meta-analysis." Journal of the American Academy of Dermatology. 2016. View Study
34. Moosbrugger-Martinz V, Leprince C, Méchin MC, Simon M, Blunder S, Gruber R, Dubrac S. "Revisiting the Roles of Filaggrin in Atopic Dermatitis." International Journal of Molecular Sciences. 2022. View Study
35. van Zuuren EJ, Fedorowicz Z, Christensen R, Lavrijsen APM, Arents BWM. "Emollients and moisturisers for eczema." Cochrane Database of Systematic Reviews. 2017. View Study
36. Spada F, Barnes TM, Greive KA. "Comparative safety and efficacy of topical mometasone furoate with other topical corticosteroids." Australasian Journal of Dermatology. 2018. View Study
37. Carr WW. "Topical Calcineurin Inhibitors for Atopic Dermatitis: Review and Treatment Recommendations." Paediatric Drugs. 2013. View Study
38. Paller AS, Marcoux D, Ramien M, et al. "Systemic Treatments in Moderate-to-Severe Atopic Dermatitis in Pediatric Patients up to 12 Years of Age: Real-World Treatment Outcomes from the PEDISTAD Registry." American Journal of Clinical Dermatology. 2025. View Study
39. Dattola A, Tolone M, Amore E, Bennardo L, Trovato F, Amato S, Grieco T, Richetta AG, Pellacani G, Skroza N, Nisticò SP. "Interleukin-13 Inhibitors in the Treatment of Atopic Dermatitis: The Role of Tralokinumab." Dermatology Practical & Conceptual. 2024. View Study
40. Chovatiya R, Paller AS. "JAK Inhibitors in the Treatment of Atopic Dermatitis." Journal of Allergy and Clinical Immunology. 2021;148(4):927–940. View Study